All bills
H.R. 5812·115th Congress·House Bill

Creating Opportunities that Necessitate New and Enhanced Connections That Improve Opioid Navigation Strategies Act of 2018

Passed House (Senate next)Track

Latest action (12 Jun 2018): On motion to suspend the rules and pass the bill Agreed to by voice vote.

What this bill does

Plain-English summary

Generate a neutral, plain-English explanation of what this bill does, who it affects and what happens next — grounded in the official text.

Official summary

Creating Opportunities that Necessitate New and Enhanced Connections That Improve Opioid Navigation Strategies Act of 2018 or the CONNECTIONS Act

This bill authorizes the Centers for Disease Control and Prevention to provide technical assistance and award grants in order to: (1) improve the efficiency and use of state prescription drug monitoring programs (PDMPs), achieve community or health system interventions relating to controlled substances (e.g., prescription guidelines), and promote new approaches to responding to emerging public health crises; and (2) improve the timeliness, comprehensiveness, and usefulness of reported overdose data.

The bill also amends the Public Health Service Act to alter requirements relating to PDMPs. Among other changes, the bill: (1) repeals requirements regarding grant formulas, database standards, and authorized data disclosures; and (2) authorizes federal support for specific improvements regarding use, data reporting, and intrastate and interstate interoperability. The Department of Health and Human Services must report on the progress of states in implementing PDMPs that are consistent with such improvements.

Timeline

  1. 12 Jun 2018

    On motion to suspend the rules and pass the bill Agreed to by voice vote.

  2. 17 May 2018

    Ordered to be Reported by Voice Vote.

Common questions

What does H.R. 5812 do?
Creating Opportunities that Necessitate New and Enhanced Connections That Improve Opioid Navigation Strategies Act of 2018 or the CONNECTIONS Act This bill authorizes the Centers for Disease Control and Prevention to provide technical assistance and award grants in order to: (1) improve the efficiency and use of state prescription drug monitoring programs (PDMPs), achieve community or health system interventions relating to controlled substances (e.g., prescription guidelines), and promote new approaches to responding to emerging public health crises; and (2) improve the timeliness, comprehensiveness, and usefulness of reported overdose data. The bill also amends the Public Health Service Act to alter requirements relating to PDMPs. Among other changes, the bill: (1) repeals requirements regarding grant formulas, database standards, and authorized data disclosures; and (2) authorizes federal support for specific improvements regarding use, data reporting, and intrastate and interstate interoperability. The Department of Health and Human Services must report on the progress of states in implementing PDMPs that are consistent with such improvements.
Has H.R. 5812 become law?
Not yet. As of 12 Jun 2018, H.R. 5812 is passed house (senate next).
Who sponsored H.R. 5812?
H.R. 5812 was sponsored by Rep. Morgan Griffith [R-VA9] (Republican-VA), with 10 cosponsors.
What's the latest action on H.R. 5812?
On motion to suspend the rules and pass the bill Agreed to by voice vote. (12 Jun 2018).

Related bills in Health

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.